DRKS00013554
Recruiting
Not Applicable
Cognition, Personality and Schizophrenia - TYPIA
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- F20
- Sponsor
- Rheinische Friedrich-Wilhelms-Universität Bonn
- Enrollment
- 200
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •For participants with high and low levels of schizotypy:
- •Age: 18\-40 years;
- •Language: sufficient knowledge of German;
- •a score above or below a certain threshold in a questionnaire for measuring schizotypy (Oxford\-Liverpool Inventory of Feelings and Experiences)
- •For schizophrenia patients:
- •Age: 18\-40 years;
- •Language: sufficient knowledge of German;
- •schizophrenia diagnosis (ICD\-10 and SCID criteria);
- •duration of illness \< 3 years
Exclusion Criteria
- •For participants with high and low levels of schizotypy:
- •alcohol dependency / abuse;
- •drug dependency / abuse;
- •current diagnosis of a psychiatric disorder assessed with the Mini International Neuropsychiatric Interview
- •o major depression
- •o dysthymia
- •o manic episode
- •o panic disorder
- •o agoraphobia
- •o social phobia
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Schizophrenia as a disorder of social cognition: an fMRI study in adolescentsschizophreniapsychosis10039628NL-OMON39432Vrije Universiteit Medisch Centrum100
Completed
Not Applicable
Neuropsychiatric Evaluation of Healthy Volunteers and Adults With SchizophreniaBrain InjuryDementiaHealthyMental DisorderSchizophreniaNCT00001323National Institute of Mental Health (NIMH)810
Completed
Not Applicable
Effects of Neurocognitive and Social Cognitive Remediation in Patients at Ultra-High Risk of PsychosisPatients at Ultra-high Risk of PsychosisNCT02098408Mental Health Services in the Capital Region, Denmark146
Completed
Phase 3
Efficacy and Safety of Asenapine With Placebo and Olanzapine (41022)(P05947)SchizophreniaNCT00151424Organon and Co277
Completed
Phase 3
Long-Term Efficacy and Safety of Asenapine Using Haloperidol as a Positive Control (41513)(COMPLETED)(P05785)SchizophreniaNCT00156065Organon and Co187